Seha, MBZUAI ink pact for clinical research

Seha, MBZUAI ink pact for clinical research

ABU DHABI / WAM

Abu Dhabi Health Services Company (Seha) has announced the signing of a Memorandum of Understanding with the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) to integrate the use of AI into the provision of medical care, enhancing clinical expertise and elevating the patient experience. The MoU was signed by Seha's Group Chief Executive Officer, Dr Gareth Goodier, and the President of MBZUAI, Professor Dr Eric Xing. With the objective of facilitating collaborative research projects, the MoU establishes a platform for Seha's clinicians and MBZUAI faculty to explore and introduce AI-driven solutions that solve prominent healthcare challenges and uplift the provision of patient-led services. In addition to the MoU, Seha and MBZUAI have also joined forces on several research agreements and projects.

One of the key focus areas both parties will explore is the development of AI-driven solutions to rapidly quantify Covid-19 infection by measuring an infection score on different lung lobes.

This will allow an accurate induction on the severity of the infection and equip physicians with the appropriate tools to identify patients who are at increased risk of developing further complications. The teams will also investigate the long-term impact of the Covid-19 virus on the UAE's residents,